AN2 Therapeutics, Inc. 10-Q

Accession 0001193125-26-344569

Filing information

CIK: 0001880438
Report date: 2026-06-30
Filing date: 2026-08-11
Form: 10-Q
Primary document: antx-20260630.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.